N-able initiated with an Overweight at JPMorgan 07:29 NABL JPMorgan analyst Sterling Auty initiated coverage of N-able with an Overweight rating and $17 price target. The analyst sees sales acceleration as likely in coming quarters, taking N-able "toward being a rule of 50 company." This should compel multiple expansion and share price outperformance, Auty tells investors in a research note.
FDA approves Ironwood's revised label for Linzess 07:11 IRWD
Enthusiast Gaming reports high of Unique Visitor traffic in the U.S. in July 07:09 EGLX Enthusiast Gaming Holdings is pleased to announce that Unique Visitor traffic in the U.S. to its digital media property has reached a 2021 high in July, based on recent data from Comscore, a leading third party media measurement and analytics company. Enthusiast Gaming's Unique Visitors in the U.S. grew to 45.3 million in July, an increase of 9% over June. That made July the highest month for U.S. Unique Visitor traffic thus far in 2021. The metric does not include additional under 18 mobile video traffic to the Company's property, or viewership in the Company's esports and entertainment division, including viewership of Luminosity Gaming.
eBay price target raised to $77 from $70 at BofA 06:36 EBAY
Switch price target raised to $28 from $23 at Citi 06:04 SWCH Citi analyst Michael Rollins raised the firm's price target on Switch to $28 from $23 and keeps a Buy rating on the shares following the "favorable" Q2 results. The analyst highlights the company's upwardly revised organic revenue growth for 2021, consideration of future real estate investment trust conversion, and steps to further improve governance and disclosure.
Evolv initiated with a Buy at Stifel 06:03 EVLV Stifel analyst Brad Reback initiated coverage of Evolv with a Buy rating and $12 price target. Reback believes the combination of a sizable TAM, with the opportunity for significant growth stemming from an expanding suite of solutions, macro trends emphasizing the need for enhanced physical security, as well as technology that is displacing legacy security systems, will allow Evolv to generate a 100% top-line CAGR through FY23, while posting increased levels of profitability and expanding free cash flow over the coming years, the analyst tells investors in a research note.

FDA approves Ironwood's revised label for Linzess 07:11 IRWD
Enthusiast Gaming reports high of Unique Visitor traffic in the U.S. in July 07:09 EGLX Enthusiast Gaming Holdings is pleased to announce that Unique Visitor traffic in the U.S. to its digital media property has reached a 2021 high in July, based on recent data from Comscore, a leading third party media measurement and analytics company. Enthusiast Gaming's Unique Visitors in the U.S. grew to 45.3 million in July, an increase of 9% over June. That made July the highest month for U.S. Unique Visitor traffic thus far in 2021. The metric does not include additional under 18 mobile video traffic to the Company's property, or viewership in the Company's esports and entertainment division, including viewership of Luminosity Gaming.
eBay price target raised to $77 from $70 at BofA 06:36 EBAY
Switch price target raised to $28 from $23 at Citi 06:04 SWCH Citi analyst Michael Rollins raised the firm's price target on Switch to $28 from $23 and keeps a Buy rating on the shares following the "favorable" Q2 results. The analyst highlights the company's upwardly revised organic revenue growth for 2021, consideration of future real estate investment trust conversion, and steps to further improve governance and disclosure.
Evolv initiated with a Buy at Stifel 06:03 EVLV Stifel analyst Brad Reback initiated coverage of Evolv with a Buy rating and $12 price target. Reback believes the combination of a sizable TAM, with the opportunity for significant growth stemming from an expanding suite of solutions, macro trends emphasizing the need for enhanced physical security, as well as technology that is displacing legacy security systems, will allow Evolv to generate a 100% top-line CAGR through FY23, while posting increased levels of profitability and expanding free cash flow over the coming years, the analyst tells investors in a research note.
- NRx Pharmaceuticals(NASDAQ:NRXP)+14% to work with cardinal health to ensure efficient distribution of potential therapies
- Lordstown Motors(NASDAQ:RIDE) +14% brings on former Icahn CEO Daniel Ninivaggi to lead company


